Accord Healthcare Inc
Accord Healthcare is a large-scale provider of generic pharmaceuticals in the United States.
THE EVOLUTION OF GENERICS
Located near the Research Triangle Park in Durham, North Carolina, Accord Healthcare Inc is an emerging large-scale provider of generic pharmaceuticals in the United States. The company is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Accord Healthcare and Intas Pharmaceuticals offer a true global distribution network and boast a presence in more than 70 countries. Over the past decade, Accord Healthcare has built the formulation expertise and manufacturing capacity to directly supply a vast portfolio of generic oral solids and injectables, complex injectables, biologics, and topicals to the regulated markets
Since 2009, the company has delivered reliable supply and quality excellence in products sold in the United States under the Accord Healthcare label. The company’s growth goals continue to be aggressive and have always been matched by its commitment to exceed its customers’ expectations. Accord Healthcare is the market share leader in more than half the product markets it supplies. Accord Healthcare is routinely cited in IMS presentations to the industry as one of the fastest-growing pharmaceutical companies in the United States. Quarter over quarter, the company consistently hits double-digit growth across all metrics: in dollar sales, number of units sold, and scripts filled. Accord Healthcare has accomplished this during multiple plant expansions across all its manufacturing sites. The company’s solid record of maintaining high-quality standards while implementing strategic commercial expansion has set it apart in the industry.
SOLID, SUSTAINABLE GROWTH Accord Healthcare’s product offerings and pipeline demonstrate its commitment to meeting the needs of health care professionals and patients alike. The company has approval for 89 abbreviated new drug applications (ANDAs) and is selling 255 dosing presentations. Accord Healthcare has 49 ANDAs pending at the FDA and more than 120 products in active development. The company’s pipeline spans a full range of drug forms: orals, topicals, transdermal patches, liquids, lyophilized agents, and peptide injectables.
Accord Healthcare is integrated in key areas, such as active pharmaceutical ingredients and pharmaceutical-component manufacturing, as well as clinical research management. The company’s research and development operation is staffed by a 450-plus team of distinguished scientific members. Its stateof-the-art labs and manufacturing infrastructure provide the right environment for true innovation. Accord Healthcare is committed to improving lives through innovation.
For more information, visit http://www.accordhealthcare.us/.